New Heart Failure Guidelines Released, but Are They Already Out of Date? Results of EMPEROR-Preserved contradict guidance Aug 27, 2021
Milder Heart Failure Might Benefit From Implantable Monitors Randomized trial signals benefit, albeit hampered by the pandemic Aug 27, 2021
Deadly Arrhythmias Less of a Risk for HF Patients on Dapagliflozin DAPA-HF analysis further explores mechanism of SGLT2 inhibitor's heart benefits Aug 27, 2021
Heart Failure Again Takes Center Stage at ESC EMPEROR-Preserved, new guidelines, and more to come Aug 26, 2021
More and More U.S. Kids Being Diagnosed With Diabetes Rises seen in both type 1 and type 2 diabetes Aug 24, 2021
Kidney Disease No Barrier to Effient Benefit in ACS Trial analysis supports superiority over ticagrelor regardless of eGFR Aug 23, 2021
Kidney Transplant Outcomes Improved Over Past Quarter-Century Patient and graft survival rates have increased since 1996 Aug 18, 2021
Watch for Eye Problems in Kids Born to Mothers With Diabetes Any type of diabetes exposure in utero increased risk for high refractive error Aug 17, 2021
Pot Smokers Face Distinct Risks After Coronary Procedures But could marijuana use be associated with fewer cases of acute kidney injury? Aug 16, 2021
Combo GIP/GLP-1 Injectable Beats Insulin for A1c Reduction All doses of once-weekly tirzepatide better than insulin degludec for HbA1c reduction Aug 11, 2021
U.S. Kids Chowed Down on Highly Processed Foods Majority of energy intake came from ready-to-eat, ultraprocessed foods in 1999-2018 Aug 10, 2021
Are Hemoglobin Cutoffs for Anemia Outdated? A growing call for WHO criteria to be tightened Aug 06, 2021
Inotrope Showdown Leaves No Winner in Cardiogenic Shock Long-awaited head-to-head comparison of milrinone and dobutamine Aug 04, 2021
TAVR Debris Deflector Doesn't Fly With FDA Advisory Panel TriGuard 3 met with skepticism in its bid for approval Aug 04, 2021
Start Rhythm Control Early for Afib With Heart Failure EAST-AFNET 4 trial finds similar benefits across ejection fraction ranges Jul 31, 2021
FDA OKs First Interchangeable Insulin Biosimilar Semglee and Lantus insulin glargine products can now be swapped by pharmacists Jul 29, 2021
SGLT2 Inhibitor Adds Years of Life to Patients With Heart Failure DAPA-HF group makes projections as long-term data are lacking Jul 28, 2021
Shingrix OK'd for Immunocompromised Adults CDC's vaccine committee currently discussing vaccine for this population, manufacturer says Jul 26, 2021
Changes in Epicardial Fat May Drive SGLT2 Inhibitor Benefits More insight into mechanisms behind empagliflozin's cardioprotection Jul 26, 2021
Surprising Tradeoffs of Valve-in-Valve TAVR vs Redo Surgery Observational study suggests excess readmissions with less invasive procedure Jul 23, 2021
Doubling Semaglutide Dose Helps Get HbA1c Under Control But when is it time to add another agent to the mix? Jul 22, 2021
Does COAPT Change the Need to Try Foundational HF Drugs in Functional MR? Current GDMT titration approach under fire during TVT debate Jul 21, 2021
After Some Early Successes for Bicuspid TAVR, a Randomized Trial May Be Unlikely Are observational data on highly selected patients good enough? Jul 21, 2021
Spinal Cord Stimulation OK'd for Diabetic Nerve Pain First device of its kind to gain FDA approval for painful diabetic neuropathy Jul 19, 2021
Dexcom's CGM Interoperability Expands; Warfarin and Osteoporosis; Maine Bans PFAS News and commentary from the endocrinology world Jul 18, 2021
Safety Concerns Turn FDA Panel Thumbs Down for Novel CKD-Anemia Drug Advisory committee rejected oral anemia drug for dialysis and non-dialysis patient populations Jul 16, 2021
'Acceptable' Lead in Drinking Water May Still Be Harmful to Patients With CKD No safe amount of lead in water for those with kidney disease, researchers warn Jul 15, 2021
Scarring on an Otherwise Normal Heart: Reassuring Data Emerge Phenomenon tied to very low burden of major arrhythmic events Jul 14, 2021
Academic Cardiologists Singled Out for Gender Equality Problem Women still poorly represented, paid in procedural internal medicine specialties Jul 12, 2021
Walmart's Low-Price Insulin Is a Band-Aid on a Broken System Exorbitant drug pricing and inaccessible care require government intervention Jul 11, 2021
Finerenone OK'd for Slowing Kidney Disease in T2D Drug also indicated for cardiovascular event risk reduction Jul 09, 2021
FDA Piles on New Warnings for Blood Volume Expanders Hydroxyethyl starch products shouldn't be used for low blood volume unless no other options exist Jul 09, 2021
Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
COVID Surges Emerge; FDA Warns About Chantix; Lions, Tigers, Bears Get Vaxxed A daily roundup of news on COVID-19 and the rest of medicine Jul 06, 2021
Regenerative Therapy Makes Headway in HF ... in the Right Patients Study of autologous skeletal cell-patch implantation in Japan Jul 02, 2021
CDC Study: Income-Related Inequalities Widening in Diabetes Disparities differed by sex and age group Jul 01, 2021
ADA 2021 Roundup: SoliMix Trial; Byetta for Teens; Driving in Hypoglycemia Noteworthy research from the American Diabetes Association virtual meeting Jun 30, 2021
Genetics, Socioeconomic Factors Each Tied to Diabetes and Obesity People with highest risk genetics more than 15 times more likely to have T2D Jun 30, 2021
Liraglutide and Insulin Come Out on Top for Glycemic Control in GRADE study Head-to-head comparison could help individualize treatment Jun 29, 2021
Resmetirom Delivers Promising Outcomes in NASH Without Invasive Follow-Up Real-world study also identifies noninvasive markers for treatment response Jun 29, 2021
